A group of researchers from the Helmholtz Munich Institute for Diabetes and Cancer (IDC) have unraveled a new strategy to alter glucagon receptor signaling in the liver by changing its intracellular ...
“Although the detailed mechanism for the stimulation of intra-islet GLP-1 secretion remains to be elucidated and further studies are required, as far as we know, our present study is the first to ...
Glucagon-like peptide-1 (GLP-1) receptor agonists, including those targeting additional pathways, help otherwise healthy people without diabetes shed pounds, albeit at the cost of some side effects, a ...
Scientists have developed a novel concept of a nose-to-brain system for the clinical application of neuropeptides. They developed a derivative of glucagon-like peptide-2 and found that when ...
Reports of emotional flattening among some users of semaglutide (Ozempic) have brought new attention to how glucagon-like ...
NEWPORT BEACH, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) ("PMGC" or the "Company") today ...
S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results